Stonepine Capital Management »

Qt Imaging Hldgs shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Qt Imaging Hldgs (QTI) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Qt Imaging Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Qt Imaging Hldgs held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qt Imaging Hldgs by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $407k 100k 4.07

More positions owned by Stonepine Capital Management

Evolus (EOLS)
Verastem Com New (VSTM)
Adma Biologics (ADMA)
Tenax Therapeutics Com New (TENX)
Nektar Therapeutics Com New (NKTR)
Ultragenyx Pharmaceutical (RARE)
Camp4 Therapeutics Corp Com 13469v Ab 4 Camtek Ltd Note 12/0 (CAMP)
Insmed Com Par $.01 Call Option (INSM)
Eloxx Pharmaceuticals Com New
Kazia Therapeutics Sponsored Ads (KZIA)
Medtronic SHS Call Option (MDT)
Indivior Pharmaceuticals (INDV)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Abbott Laboratories Call Option (ABT)
Satellos Bioscience (MSLE)

View all positions for Stonepine Capital Management

Top funds holding Qt Imaging Hldgs

Lynrock Lake
Alyeska Investment Group
Vanguard Capital Management
Bleichroeder
Geode Capital Management
Citadel Advisors
Stonepine Capital Management
Perkins Capital Management
BlackRock
Millennium Management
Polar Securities
Vanguard Fiduciary Trust
Ronald Blue Trust
Northern Trust
Oxford Financial

View all funds holding Qt Imaging Hldgs